中文
SETTING A NEW STANDARD
HOW WE HELP
AmbioPharm has developed a unique business model designed to handle expedited peptide manufacturing at a lower cost than most major competitors.
With one of the largest peptide manufacturing capacities in the world, AmbioPharm is currently expanding both in the USA and China. With the new construction, we are more than tripling our peptide synthesis capacity.
We employ more than 500 chemists and industry professionals at our two locations. Superior chemistry and facilities enable us to provide best-in-class quality with efficient and timely production.
We can produce projects of any scale. AmbioPharm has multiple manufacturing suites capable of producing peptide APIs at varying scales from gram to multi-kilogram scale. Recently, we have added a small-scale CEM Liberty Blue Microwave synthesizer to aid with small-scale non-GMP peptide projects. This helps speed delivery of these early stage projects to our partners to facilitate their discovery efforts.
AmbioPharm has handled products in every phase of development from pre-clinical to R&D to commercialization, including analytical method and validation protocol services.
EXPLORE OUR
The professionals at AmbioPharm have more than 150 years of cumulative experience in process development, scale up, and GMP services.
We provide process development and analytical services for non-GMP grade peptides for a broad range of customers.
AmbioPharm partners with generic drug companies to develop generic peptide drugs for established commercial markets throughout the world.
AmbioPharm has years of experience manufacturing Active Peptide Ingredients for peptide vaccines in varying configurations.
During the development process is underway, we develop analytical HPLC methods and write the analytical method validation protocol.
More than 40 experienced Quality Assurance staff and consultants review operations throughout the design and manufacturing process.
AmbioPharm has over 150 years of cumulative experience in process development, scale up, and cGMP (Current Good Manufacturing Practice standards as defined by the FDA). We can manufacture GMP peptides using solution phase (liquid phase), solid phase peptide synthesis (SPPS), or hybrid processes.
We provide rigid quality controls, standard operating procedures (SOPs), training, and rigorous testing to maintain quality and consistency.
AmbioPharm complies with all FDA inspections and PAIs while demonstrating a commitment to the highest levels of quality.
We provide products and services to Pharmaceutical companies, Clinical Research labs, Universities, Biotech companies, and others.
We provide products and services to Pharmaceutical Companies, Clinical Research Labs, Universities, Biotech Companies, and others.
Pharmaceutical Companies
We manufacture peptide APIs for some of the world’s largest pharmaceutical companies, but we can also handle small batch projects.
Clinical Research Labs
AmbioPharm produces peptide products to cGMP standards and provides process development and analytical services for non-GMP peptides.
